D'INCALCI, MAURIZIO
D'INCALCI, MAURIZIO
Dipartimento Scienze Biomediche
"The Art of Successful Publication" ECCO 13 workshop report
2006-01-01 Smyth, J; Verweij, J; D'Incalci, M; Balakrishnan, L
3-methyladenine-DNA-glycosylase and O-6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines
1996-01-01 Damia, G; Imperatori, L; Citti, L; Mariani, L; D'Incalci, M
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study
2014-01-01 Zambelli, A; Tancredi, R; Negri, S; Cattrini, C; Ponchio, L; Frascaroli, M; Da Prada GA Fregoni, V; Pavesi, L; Riccardi, A; Zucchett, M; Nerini, If; D'Incalci, M
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors
2016-01-01 Giordano, S; Morosi, L; Veglianese, P; A Licandro, S; Frapolli, R; Zucchetti, M; Cappelletti, G; Falciola, L; Pifferi, V; Visentin, S; D'Incalci, M; Davoli, E
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma
2014-01-01 Lupi, M; Colombo, C; Frapolli, R; Ferrari, R; Sitia, L; Dragoni, L; Bello, E; Licandro, Sa; Falcetta, F; Ubezio, P; Bigini, P; Salmona, M; D'Incalci, M; Morbidelli, M; Moscatelli, D
A comprehensive investigation of histotype-specific microRNA and their variants in stage I epithelial ovarian cancers
2023-01-01 Velle, Angelo; Pesenti, Chiara; Grassi, Tommaso; Beltrame, Luca; Martini, Paolo; Jaconi, Marta; Agostinis, Federico; Calura, Enrica; Katsaros, Dionyssios; Borella, Fulvio; Fruscio, Robert; D'Incalci, Maurizio; Marchini, Sergio; Romualdi, Chiara
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin
2012-01-01 Grosso, F; D'Incalci, M; Cartoafa, M; Nieto, A; Fernandez-Teruel, C; Alfaro, V; Lardelli, P; Roy, E; Gomez, J; Kahatt, C; Soto-Matos, A; Judson, I
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action
2017-01-01 Campaner, E; Rustighi, A; Zannini, A; Cristiani, A; Piazza, S; Ciani, Y; Kalid, O; Golan, G; Baloglu, E; Shacham, S; Valsasina, B; Cucchi, U; Pippione, Ac; Lolli, Ml; Giabbai, B; Storici, P; Carloni, P; Rossetti, G; Benvenuti, F; Bello, E; D'Incalci, M; Cappuzzello, E; Rosato, A; Del Sal, G
A dose dense schedule improves antitumor activity of trabectedin in myxoid liposarcoma with type III FUS-CHOP chimera
2014-01-01 Uboldi, S; Frapolli, R; Bello, E; Brich, S; Bozzi, F; Sanfilippo, R; Casali, Pg; Gronchi, A; Galmarini, Cm; Sousa-Faro, Jmf; Pilotti, S; D'Incalci, M
A FILTER INCUBATION METHOD FOR THE DETERMINATION OF POTENTIALLY CROSSLINKABLE SITES IN DNA IN MAMMALIAN-CELLS
1985-01-01 D'Incalci, M; Szmigiero, L; Erickson, Lc; Hartley, Ja; Kohn, Kw
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma
2013-01-01 Gallerani, E; Zucchetti, M; Brunelli, D; Marangon, E; Noberasco, C; Hess, D; Delmonte, A; Martinelli, G; Bohm, S; Driessen, C; De Braud, F; Marsoni, S; Cereda, R; Sala, F; D'Incalci, M; Sessa, C
A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging
2017-01-01 Giordano, S; Pifferi, V; Morosi, L; Morelli, M; Falciola, L; Cappelletti, G; Visentin, S; Licandro, Sa; Frapolli, R; Zucchetti, M; Pastorelli, R; Brunelli, L; D'Incalci, M; Davoli, E
A novel taxane active against an orthotopically growing human glioma xenograft
2001-01-01 Laccabue, D; Tortoreto, M; Veneroni, S; Perego, P; Scanziani, E; Zucchetti, M; Zaffaroni, M; D'Incalci, M; Bombardelli, E; Zunino, F; Pratesi, G
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia
2006-01-01 Rizzari, C; Citterio, M; Zucchetti, M; Conter, V; Chiesa, R; Colombini, A; Malguzzi, S; Silvestri, D; D'Incalci, M
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
2018-01-01 Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M
A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment
2016-01-01 Calura, E; Paracchini, L; Fruscio, R; Difeo, A; Ravaggi, A; Peronne, J; Martini, P; Sales, G; Beltrame, L; Bignotti, E; Tognon, G; Milani, R; Clivio, L; Dell'Anna, T; Cattoretti, G; Katsaros, D; Sartori, E; Mangioni, C; Ardighieri, L; D'Incalci, M; Marchini, S; Romualdi, C
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
2010-01-01 D'Incalci, M; Galmarini, Cm
A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
2012-01-01 Scarpati, Gd; Falcetta, F; Carlomagno, C; Ubezio, P; Marchini, S; De Stefano, A; Singh, Vk; D'Incalci, M; De Placido, S; Pepe, S
A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma
2012-01-01 Uboldi, S; Calura, E; Beltrame, L; Nerini, If; Marchini, S; Cavalieri, D; Erba, E; Chiorino, G; Ostano, P; D'Angelo, D; D'Incalci, M; Romualdi, C
A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia
2016-01-01 Mannarino, L; Paracchini, L.; Craparotta, I.; Romano, M.; Marchini, S.; Gatta, R.; Erba, E.; Clivio, L.; Romualdi, Chiara; D'Incalci, Maurizio; Beltrame, L.; Pattini, L.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
"The Art of Successful Publication" ECCO 13 workshop report | 1-gen-2006 | Smyth, J; Verweij, J; D'Incalci, M; Balakrishnan, L | |
3-methyladenine-DNA-glycosylase and O-6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines | 1-gen-1996 | Damia, G; Imperatori, L; Citti, L; Mariani, L; D'Incalci, M | |
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study | 1-gen-2014 | Zambelli, A; Tancredi, R; Negri, S; Cattrini, C; Ponchio, L; Frascaroli, M; Da Prada GA Fregoni, V; Pavesi, L; Riccardi, A; Zucchett, M; Nerini, If; D'Incalci, M | |
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors | 1-gen-2016 | Giordano, S; Morosi, L; Veglianese, P; A Licandro, S; Frapolli, R; Zucchetti, M; Cappelletti, G; Falciola, L; Pifferi, V; Visentin, S; D'Incalci, M; Davoli, E | |
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma | 1-gen-2014 | Lupi, M; Colombo, C; Frapolli, R; Ferrari, R; Sitia, L; Dragoni, L; Bello, E; Licandro, Sa; Falcetta, F; Ubezio, P; Bigini, P; Salmona, M; D'Incalci, M; Morbidelli, M; Moscatelli, D | |
A comprehensive investigation of histotype-specific microRNA and their variants in stage I epithelial ovarian cancers | 1-gen-2023 | Velle, Angelo; Pesenti, Chiara; Grassi, Tommaso; Beltrame, Luca; Martini, Paolo; Jaconi, Marta; Agostinis, Federico; Calura, Enrica; Katsaros, Dionyssios; Borella, Fulvio; Fruscio, Robert; D'Incalci, Maurizio; Marchini, Sergio; Romualdi, Chiara | |
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin | 1-gen-2012 | Grosso, F; D'Incalci, M; Cartoafa, M; Nieto, A; Fernandez-Teruel, C; Alfaro, V; Lardelli, P; Roy, E; Gomez, J; Kahatt, C; Soto-Matos, A; Judson, I | |
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action | 1-gen-2017 | Campaner, E; Rustighi, A; Zannini, A; Cristiani, A; Piazza, S; Ciani, Y; Kalid, O; Golan, G; Baloglu, E; Shacham, S; Valsasina, B; Cucchi, U; Pippione, Ac; Lolli, Ml; Giabbai, B; Storici, P; Carloni, P; Rossetti, G; Benvenuti, F; Bello, E; D'Incalci, M; Cappuzzello, E; Rosato, A; Del Sal, G | |
A dose dense schedule improves antitumor activity of trabectedin in myxoid liposarcoma with type III FUS-CHOP chimera | 1-gen-2014 | Uboldi, S; Frapolli, R; Bello, E; Brich, S; Bozzi, F; Sanfilippo, R; Casali, Pg; Gronchi, A; Galmarini, Cm; Sousa-Faro, Jmf; Pilotti, S; D'Incalci, M | |
A FILTER INCUBATION METHOD FOR THE DETERMINATION OF POTENTIALLY CROSSLINKABLE SITES IN DNA IN MAMMALIAN-CELLS | 1-gen-1985 | D'Incalci, M; Szmigiero, L; Erickson, Lc; Hartley, Ja; Kohn, Kw | |
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma | 1-gen-2013 | Gallerani, E; Zucchetti, M; Brunelli, D; Marangon, E; Noberasco, C; Hess, D; Delmonte, A; Martinelli, G; Bohm, S; Driessen, C; De Braud, F; Marsoni, S; Cereda, R; Sala, F; D'Incalci, M; Sessa, C | |
A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging | 1-gen-2017 | Giordano, S; Pifferi, V; Morosi, L; Morelli, M; Falciola, L; Cappelletti, G; Visentin, S; Licandro, Sa; Frapolli, R; Zucchetti, M; Pastorelli, R; Brunelli, L; D'Incalci, M; Davoli, E | |
A novel taxane active against an orthotopically growing human glioma xenograft | 1-gen-2001 | Laccabue, D; Tortoreto, M; Veneroni, S; Perego, P; Scanziani, E; Zucchetti, M; Zaffaroni, M; D'Incalci, M; Bombardelli, E; Zunino, F; Pratesi, G | |
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia | 1-gen-2006 | Rizzari, C; Citterio, M; Zucchetti, M; Conter, V; Chiesa, R; Colombini, A; Malguzzi, S; Silvestri, D; D'Incalci, M | |
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma | 1-gen-2018 | Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M | |
A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment | 1-gen-2016 | Calura, E; Paracchini, L; Fruscio, R; Difeo, A; Ravaggi, A; Peronne, J; Martini, P; Sales, G; Beltrame, L; Bignotti, E; Tognon, G; Milani, R; Clivio, L; Dell'Anna, T; Cattoretti, G; Katsaros, D; Sartori, E; Mangioni, C; Ardighieri, L; D'Incalci, M; Marchini, S; Romualdi, C | |
A Review of Trabectedin (ET-743): A Unique Mechanism of Action | 1-gen-2010 | D'Incalci, M; Galmarini, Cm | |
A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | 1-gen-2012 | Scarpati, Gd; Falcetta, F; Carlomagno, C; Ubezio, P; Marchini, S; De Stefano, A; Singh, Vk; D'Incalci, M; De Placido, S; Pepe, S | |
A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma | 1-gen-2012 | Uboldi, S; Calura, E; Beltrame, L; Nerini, If; Marchini, S; Cavalieri, D; Erba, E; Chiorino, G; Ostano, P; D'Angelo, D; D'Incalci, M; Romualdi, C | |
A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia | 1-gen-2016 | Mannarino, L; Paracchini, L.; Craparotta, I.; Romano, M.; Marchini, S.; Gatta, R.; Erba, E.; Clivio, L.; Romualdi, Chiara; D'Incalci, Maurizio; Beltrame, L.; Pattini, L. |